To provide a concise introduction to the Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 and guide readers using the bare text of the Act.
Overview #
The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017 is a central Indian legislation enacted to prevent and control the spread of HIV and AIDS while protecting the dignity, privacy and human rights of persons who are HIV-positive, affected by HIV or AIDS, or vulnerable to HIV.
The Act is significant for healthcare institutions, doctors, pharmacists, testing centres, employers, educational institutions, correctional institutions, lawyers and public authorities because it creates enforceable obligations relating to non-discrimination, informed consent, confidentiality of HIV status, access to treatment, safe working environments and grievance redressal.
The Act is Act No. 16 of 2017, dated 20 April 2017. The extracted text indicates that it came into force on 10 September 2018 by Central Government notification and extends to the whole of India.
Object of the legislation #
The object of the Act is not limited to medical control of HIV infection. It combines public health objectives with a rights-based framework. The preamble records the need to prevent and control HIV and AIDS, secure the human rights of persons who are HIV-positive or affected by HIV and AIDS, provide effective care, support and treatment, and protect healthcare providers and other persons dealing with HIV and AIDS related matters.
The Act also reflects India’s international commitment under the United Nations Declaration of Commitment on HIV/AIDS, 2001. Its core legislative purpose is to reduce stigma and discrimination so that persons can seek testing, counselling, care and treatment without fear of exclusion or disclosure.
Scope and relevance #
The Act applies across areas where HIV status may affect a person’s civil rights, access to services, employment, education, healthcare and family life. It is particularly relevant in hospitals, clinics, blood banks, laboratories, pharmacies connected with treatment access, workplaces, educational institutions, insurance and housing-related contexts, and custodial settings.
For healthcare and pharmaceutical law users, the Act is important because it regulates the conditions under which HIV testing and treatment may be undertaken, requires informed consent subject to limited exceptions, protects confidentiality of medical information, recognises anti-retroviral therapy and opportunistic infection management, and requires establishments to create safe working environments and grievance mechanisms.
For lawyers and legal researchers, the Act is also relevant because it contains special provisions on suppression of identity in court proceedings, speedy handling of maintenance applications involving affected persons, penalties for contravention and breach of confidentiality, and an overriding clause giving the Act priority over inconsistent laws.
Selected important provisions and themes #
- Section 3 prohibits discrimination on HIV-related grounds, making it the central rights-protection provision of the Act.
- Sections 5 and 6 deal with informed consent for HIV testing or treatment and the limited situations where consent is not required.
- Sections 8 and 9 regulate disclosure of HIV status, including disclosure to a partner of an HIV-positive person in specified circumstances.
- Sections 11 and 12 impose obligations on establishments regarding confidentiality of data and HIV and AIDS policies.
- Sections 13 and 14 require the Central Government and State Governments to take measures relating to anti-retroviral therapy and opportunistic infection management.
- Sections 19 to 21 concern safe working environments, general responsibilities of establishments and grievance redressal mechanisms.
- Sections 23 to 28 provide for appointment, powers, procedure and reporting functions of the Ombudsman.
- Sections 34 to 43 cover special court procedure, penalties, cognizable and bailable offences, prohibition of victimisation and the Act’s overriding effect.
How to use this Bare Act #
- Use this bare Act to check the exact statutory language on HIV-related discrimination, informed consent, disclosure and confidentiality.
- Healthcare establishments should read the Act with their internal patient privacy, counselling, laboratory testing, workplace safety and grievance redressal policies.
- Law students and legal researchers should focus on the structure of the Act: rights protection, healthcare duties, welfare measures, institutional obligations, Ombudsman mechanism and penalties.
- Practitioners should verify whether any applicable Central or State rules, notifications, guidelines or establishment-specific policies apply to the particular issue.
- When advising on court filings or disputes involving HIV status, pay special attention to the provisions on suppression of identity, confidentiality and victimisation.
Related Bare Acts and statutes #
- Clinical Establishment (Registration and Regulation) Act
- Drugs and Cosmetics Act, 1940 with Rules 1945
- Biomedical Waste Management Rules, 2016
- The Transplant of Human Organs and Tissues Act, 1994
- Protection of Human Rights, 1993
This page is intended as a convenient bare Act reference. Users should verify the latest text of the Act, commencement notifications, rules, State-level implementation measures and any current official guidelines before relying on it for legal advice, compliance or litigation.
